William Rhodes

William Rhodes

Chairman bei GENINCODE PLC

Vermögen: 1 043 $ am 31.03.2024

70 Jahre
Health Technology
Commercial Services
Finance

Profil

William E.
Rhodes
is the founder of BD Ventures LLC.
He currently holds the following positions: Chairman-Supervisory Board at Curetis GmbH, Executive Chairman at Nodexus, Inc., Independent Non-Executive Chairman at GENinCode Plc, Director at OncoDNA SA, Director at Cellector Corp., Director at Conticare Medical, Inc., Non-Executive Director at Endosound, Inc., and Operating Partner at Altaris Capital Partners LLC.
Previously, he served as Chairman-Supervisory Board at Curetis NV from 2015 to 2020, Chairman-Supervisory Board at CytoSMART Technologies BV, Non-Executive Chairman at OpGen, Inc. from 2020 to 2024, Non-Executive Director at Vitro Biopharma, Inc., Director at VitaGen, Inc., Independent Non-Executive Director at Andor Technology Ltd.
from 2013 to 2014, Non-Executive Director at Cambridge Nutritional Sciences Plc from 2013 to 2022, Director at California Healthcare Institute, Director at Silicon Valley Leadership Group, Director at San José State University Research Foundation, Director at Paramit Corp.
from 2014 to 2022, Director at Novocell, Inc. (Old), Director at Omega Group Plc from 2013 to 2022, Director at Third Day Advisors LLC, Senior VP-Corporate Strategy & Development at Becton, Dickinson & Co. from 2011 to 2013, Vice President at Johnson & Johnson Innovation - JJDC, Inc., Operating Partner at Linden Manager LLC from 2013 to 2016, Worldwide President at BD Biosciences, Systems & Reagents, Inc. from 2009 to 2011, Principal at Pfizer Central Research, Member-Dean's Council at Cornell University College of Agriculture & Life Sciences, and President at The William-James Co. He obtained his undergraduate degree from Cornell University and his graduate degree from Seton Hall University.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
30.06.2023 1 500 ( 0,01% ) 1 043 $ 31.03.2024

Aktive Positionen von William Rhodes

UnternehmenPositionBeginn
GENINCODE PLC Chairman 01.01.2021
Director/Board Member -
Director/Board Member -
Director/Board Member -
Private Equity Investor -
Chairman 18.03.2024
Chairman -
Cellector Corp. Director/Board Member 01.01.2015
Alle aktiven Positionen von William Rhodes

Ehemalige bekannte Positionen von William Rhodes

UnternehmenPositionEnde
OPGEN, INC. Chairman 25.03.2024
░░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░ ░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░░░░ ░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
Sehen Sie sich die Erfahrung von William Rhodes im Detail an

Ausbildung von William Rhodes

Cornell University Undergraduate Degree
Seton Hall University Graduate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von William Rhodes im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

32

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen4
BECTON, DICKINSON AND COMPANY

Health Technology

OPGEN, INC.

Commercial Services

CAMBRIDGE NUTRITIONAL SCIENCES PLC

Health Technology

GENINCODE PLC

Technology Services

Private Unternehmen25

Process Industries

Finance

Health Technology

Electronic Technology

Finance

Finance

Health Technology

Finance

California Healthcare Institute

Health Technology

Commercial Services

Pfizer Central Research

Commercial Services

Health Technology

Health Technology

Novocell, Inc. (Old)

Health Technology

Omega Group Plc

Health Services

Health Services

Third Day Advisors LLC

Commercial Services

Cellector Corp.

Miscellaneous

Health Technology

Distribution Services

The William-James Co.

Commercial Services

Health Technology

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. William Rhodes